The available evidence for short-term psychodynamic psychotherapies (STPP) for chronic pain counters the notion 1 that there are no published studies of psychodynamic methods in these populations.
In performing recent systematic reviews, 2 we have found a total of 24 published studies of individual and group STPPs for a range of somatic conditions. Among these, 9 studied chronic pain conditions. [3] [4] [5] [6] [7] [8] [9] [10] [11] Four were mixed chronic pain populations, 3-6 2 were for chronic headache, 7,8 one was for rheumatoid arthritis and Sjrogen's syndrome, 9 one was for chronic back pain, 10 and one was for pelvic pain and urethral syndrome. 11 A further 6 were for mixed somatoform syndromes and conditions including Crohn disease, which often includes chronic pain.
Among 4 randomized trials including chronic pain patients, 3 4,5,9 outperformed the medical treatment as usual with no treatment controls, while a fourth 3 yielded equal (and limited) effects, compared with 6 sessions of a cognitive form of supportive therapy. The remaining noncontrolled trials reported significant gains, compared with pretreatment symptom measures. 6, 7, 10, 11 In our Cochrane review of STPP, compared with minimal treatment and waitlist controls, STPP was efficacious in ameliorating somatic symptoms in the short, medium, and long term, compared with minimal treatment and waitlist controls. 2 Thus there is a modest and growing body of evidence for brief psychodynamic treatments in chronic pain populations.
